Therapeutic Asset Ratings
8,400 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
met233
Obesity Disorder
Pfizer
P1/2
B
(57)
Nbm-Bmx
Cancer
Novelwise Pharmaceutical Corporation
P1/2
B
(57)
Ngfr-Transduced Autologous T Lymphocytes
Cutaneous Melanoma
M.D. Anderson Cancer Center
P1/2
B
(57)
Nivolumab
Acute Lymphoblastic Leukemia
Assistance Publique - Hôpitaux de Paris
P1/2
B
(57)
Nivolumab
Solid Tumor, Adult
ImmuneSensor Therapeutics Inc.
P1/2
B
(57)
Nivolumab
Malignant Colon Neoplasm
M.D. Anderson Cancer Center
P1/2
B
(57)
Osimertinib
EGFR Mutation-Related Tumors
Shanghai EpimAb Biotherapeutics Co., Ltd.
P1/2
B
(57)
Palbociclib
KRAS Gene Mutation
Calithera Biosciences, Inc
P1/2
B
(57)
Palbociclib
Acute Lymphoblastic Leukemia
Tanja Andrea Gruber
P1/2
B
(57)
Palbociclib
Refractory Acute Lymphoblastic Leukemia
Tanja Andrea Gruber
P1/2
B
(57)
Pamiparib
Grade II Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
B
(57)
Pamiparib
Grade III Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
B
(57)
Pembrolizumab
Adult Glioblastoma
University Hospital, Geneva
P1/2
B
(57)
Pembrolizumab
Mantle Cell Lymphoma
Celldex Therapeutics
P1/2
B
(57)
Pembrolizumab
Stage IVb Bladder Cancer
M.D. Anderson Cancer Center
P1/2
B
(57)
PREDNISONE TABLETS
Cancer of Rectum
Hospital San Carlos, Madrid
P1/2
B
(57)
PREDNISONE TABLETS
Mature B-Cell Malignancies
BeOne Medicines
P1/2
B
(57)
PREDNISONE TABLETS
Prolymphocytic Leukemia
Acerta Pharma BV
P1/2
B
(57)
PREDNISONE TABLETS
Refractory Chronic Myelomonocytic Leukemia
Indiana University
P1/2
B
(57)
Pyrotinib
Advanced Gastroesophageal Junction Cancer
BeOne Medicines
P1/2
B
(57)
Rhil-7
Lymphoma, Non-hodgkins
Medical College of Wisconsin
P1/2
B
(57)
rn1701
B-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P1/2
B
(57)
Sargramostim
Gastric Adenocarcinoma
Mayo Clinic
P1/2
B
(57)
Snb-101
Small Cell Lung Carcinoma
SN BioScience
P1/2
B
(57)
SPL026
Major Depressive Disorder
Small Pharma Ltd
P1/2
B
(57)
Showing 151 to 175 of 8,400 assets
Previous
Page 7 of 336
Next